Clinical trial · Observational
Knowledge and Perception of Clinical Trial Participation in Breast Cancer Patients in Egypt
Knowledge and Perception of Clinical Trial Participation in Breast Cancer Female Patients in Egypt, a Cross Sectional Study
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
* Clinical trials are essential to translate new therapy concepts or rather any intervention into the medical routine. Beside the well designed trial protocol, the success of clinical trials depends on patient recruitment and participation. * This study aims to get a current picture of the patients' knowledge and perception of clinical trial participation in Breast cancer female patients in Egypt, as an example to Low/Middle income countries.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
| Clinical Trials | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Knowledge and perception of clinical trial participation | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- The percentage of breast cancer patients who accept to participate in clinical trials
- timeFrame
- 1 year
Secondary outcomes (1)
- measure
- The barriers for participation in clinical trials
- timeFrame
- 1 year
Eligibility
Eligibility (as posted)
- Sex
- Female
- Maximum age
- 80 Years
Show eligibility criteria text
Inclusion Criteria: * Female breast cancer patients Exclusion Criteria: * Patients who refuse participation
References
Publications (0)
Data not yet available